Andere Sprachen PaxMedica, Inc.

Aktien

A3EWHT

US70424C2035

PXMD

Markt geschlossen - OTC Markets Andere Börsenplätze 21:57:22 25.06.2024			% 5 Tage	% 1. Jan.
0.21 ^USD	-4.59%		-4.59%	-72.26%

13.05.	PaxMedica, Inc. meldet Ergebnis für das erste Quartal bis zum 31. März 2024	CI
23.04.	Paxmedica, Inc. reagiert auf dringende Anfrage nach IV-Suramin und verpflichtet sich, sofortigen Zugang zu PAX-101 zu gewähren	CI

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101	15.05.
PaxMedica, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	13.05.
PaxMedica Provides Company Update and Continues to Advance PAX-101 Regulatory Strategy	07.05.
PaxMedica, Inc.(NasdaqCM:PXMD) dropped from S&P TMI Index	06.05.
PaxMedica, Inc.(NasdaqCM:PXMD) dropped from NASDAQ Composite Index	01.05.
PaxMedica's CEO and Malawi Health Official Discuss Urgent Medical Crisis in Bell2Bell Podcast	26.04.
Paxmedica, Inc. Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101	23.04.
PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101	23.04.
PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness	16.04.
PaxMedica, Inc. Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness	16.04.
Sector Update: Health Care Stocks Slipping Late Afternoon	12.04.
Top Midday Gainers	12.04.
Major US Banks' Lower Earnings Drag Down Exchange-Traded Funds, Equity Futures Pre-Bell Friday	12.04.
PaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA Submission	11.04.
PaxMedica, Inc. Achieves Key Milestone in the Development of Pax-101 and Provides Update on Potential NDA Submission	11.04.
PaxMedica : Certificate of Incorporation/Bylaws - Form 8-K	22.03.
PaxMedica Updated Company Presentation Highlighting Innovations in Autism Spectrum Disorder Treatments	13.03.
PaxMedica, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	11.03.
Certain Warrants of PaxMedica, Inc. are subject to a Lock-Up Agreement Ending on 19-FEB-2024.	19.02.
Certain Common Stock of PaxMedica, Inc. are subject to a Lock-Up Agreement Ending on 19-FEB-2024.	19.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen PaxMedica, Inc.

Aktien

A3EWHT

US70424C2035

PXMD

Andere Sprachen

Filter